US: Will Trump Officials overseeing Amazon-Whole Foods merger face conflicts of interest?
The blockbuster deal by Amazon to purchase Whole Foods rocked financial markets on Friday. Grocery and retail outlet stocks were in a tailspin anticipating how the online shopping giant may move to swallow up the supermarket industry, particularly in the booming online sales market.
The massive $13.7 billion Amazon-Whole Foods merger may also invite government oversight regarding antitrust concerns, a dynamic complicated by potential conflicts of interest from officials tied to the merger.
Officials from both the Justice Department and the Federal Trade Commission, the two agencies charged with enforcing antitrust law, have financial ties to the law firms expected to play a major role in managing the deal.
President Donald Trump’s pick to lead the Justice Department’s antitrust division, Makan Delrahim, has worked since 2005 as a lawyer and lobbyist at Brownstein Hyatt Farber Schreck, a firm that is registered to lobby on behalf of Amazon.
Delrahim, who has worked on merger deals for over a decade and is viewed by legal observers as less likely to pursue aggressive antitrust enforcement as the previous administration, will be in office to review the Amazon-Whole Foods deal soon. He was nominated in March and was cleared by the Senate Judiciary Committee this month, making his appointment imminent.
Delrahim, however, isn’t the only official with ties to the merger. Abbott Lipsky, appointed in March as the new acting Director of the FTC’s Bureau of Competition, which oversees antitrust, previously worked as a partner in the antitrust division of the law firm Latham & Watkins. Lipsky’s former law firm has been tapped by Whole Foods’ financial adviser, Evercore, to help manage the merger with Amazon, according to Law360.
Full Content: Law 360
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Top Antitrust Expert Joins Cravath from Paul Weiss
Jan 21, 2025 by
CPI
CMA Chief Removed as UK Government Targets Regulatory Overhaul
Jan 21, 2025 by
CPI
Court Denies Dismissal in Crab Price-Fixing Lawsuit
Jan 21, 2025 by
CPI
TikTok Stays Online for Now: Trump Floats US Ownership Deal
Jan 21, 2025 by
CPI
Hong Kong Watchdog Unveils Compliance Tool for Small Businesses
Jan 21, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Pharmacy Benefit Managers
Jan 20, 2025 by
CPI
Untangling the PBM Mess
Jan 20, 2025 by
Kent Bernard
Using Data, Not Anecdotes, to Analyze Criticisms of Pharmacy Benefit Managers
Jan 20, 2025 by
Dennis Carlton
Vertical Integration and PBMs: What, Me Worry?
Jan 20, 2025 by
Lawton Robert Burns & Bradley Fluegel
The Economics of Benefit Management in Prescription-Drug Markets
Jan 20, 2025 by
Casey B. Mulligan